NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 149 filers reported holding NEKTAR THERAPEUTICS in Q2 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 13,675 | $8 | 0.00% |
| XTX Topco Ltd | 11,826 | $6,802 | 0.00% |
| Qube Research & Technologies Ltd | 378,398 | $217,655 | 0.00% |
| Founders Capital Management | 1,500 | $863 | 0.00% |
| Squarepoint Ops LLC | 814,799 | $468,672 | 0.00% |
| FIRST CITIZENS BANK & TRUST CO | 98,129 | $56,443 | 0.00% |
| Citadel Advisors | 9,703,652 | $5,581,541 | 0.00% |
| Verition Fund Management LLC | 90,000 | $51,768 | 0.00% |
| FEDERATED HERMES, INC. | 747,276 | $429,684 | 0.00% |
| Invesco Ltd. | 5,535,430 | $3,183,979 | 0.00% |
| HRT FINANCIAL LP | 234,257 | $134 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 4,470,818 | $2,571,615 | 0.00% |
| Ergoteles LLC | 37,500 | $21,570 | 0.00% |
| Tower Research Capital LLC (TRC) | 45,806 | $26,338 | 0.00% |
| FRANKLIN STREET ADVISORS INC /NC | 15,500 | $9 | 0.00% |
| ROPES WEALTH ADVISORS LLC | 11,580 | $6,661 | 0.00% |
| Quantbot Technologies LP | 20,952 | $12,052 | 0.00% |
| Laurion Capital Management LP | 84,744 | $48,745 | 0.00% |
| Steward Partners Investment Advisory, LLC | 200 | $115 | 0.00% |
| Financial Advocates Investment Management | 10,550 | $6,068 | 0.00% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q2 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.